Literature DB >> 20658912

Lung cancer in women: role of estrogens.

Subhankar Chakraborty1, Apar Kishor Ganti, Alissa Marr, Surinder K Batra.   

Abstract

The incidence of lung cancer in females is increasing, in contrast to that seen in males. In addition, the proportion of lung cancer cases in women attributable to smoking is approximately half of that seen in males. Female sex hormones, especially estrogen, may play a key role in this. Estrogen receptors ERalpha and ERbeta have been detected on lung cancer cells and there is new evidence suggesting that hormone-replacement therapy may increase both the incidence of, and mortality from, lung cancer in women. Laboratory evidence lends credence to the carcinogenic effects of estrogens in lung cancer. This article summarizes the current evidence on their role in lung cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20658912      PMCID: PMC2928145          DOI: 10.1586/ers.10.50

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  50 in total

1.  A lung cancer responding to hormonal therapy.

Authors:  Ian M Collins; Siobhan A Nicholson; Ken J O'Byrne
Journal:  J Thorac Oncol       Date:  2010-05       Impact factor: 15.609

Review 2.  Androgen production in women.

Authors:  Henry G Burger
Journal:  Fertil Steril       Date:  2002-04       Impact factor: 7.329

3.  Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends.

Authors:  H L Howe; P A Wingo; M J Thun; L A Ries; H M Rosenberg; E G Feigal; B K Edwards
Journal:  J Natl Cancer Inst       Date:  2001-06-06       Impact factor: 13.506

4.  Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex.

Authors:  Ann G Schwartz; Geoffrey M Prysak; Valerie Murphy; Fulvio Lonardo; Harvey Pass; Jan Schwartz; Sam Brooks
Journal:  Clin Cancer Res       Date:  2005-10-15       Impact factor: 12.531

5.  A phase III trial evaluating the combination of cisplatin, etoposide, and radiation therapy with or without tamoxifen in patients with limited-stage small cell lung cancer: Cancer and Leukemia Group B Study (9235).

Authors:  Edward F McClay; Jeff Bogart; James E Herndon; Dee Watson; Lisa Evans; Steven L Seagren; Mark R Green
Journal:  Am J Clin Oncol       Date:  2005-02       Impact factor: 2.339

6.  Hormone replacement therapy is associated with decreased survival in women with lung cancer.

Authors:  Apar Kishor Ganti; Abe E Sahmoun; Amit W Panwalkar; Ketki K Tendulkar; Anil Potti
Journal:  J Clin Oncol       Date:  2005-11-28       Impact factor: 44.544

7.  Estrogen and progesterone receptors in non small cell lung cancer patients.

Authors:  Elzbieta Radzikowska; Renata Langfort; Dorota Giedronowicz
Journal:  Ann Thorac Cardiovasc Surg       Date:  2002-04       Impact factor: 1.520

8.  Estrogen and progesterone receptors in non-small cell lung cancer in 248 consecutive patients who underwent surgical resection.

Authors:  L Di Nunno; L G Larsson; J J Rinehart; R S Beissner
Journal:  Arch Pathol Lab Med       Date:  2000-10       Impact factor: 5.534

9.  Going up or coming down? The changing phases of the lung cancer epidemic from 1967 to 1999 in the 15 European Union countries.

Authors:  F Bray; J E Tyczynski; D M Parkin
Journal:  Eur J Cancer       Date:  2004-01       Impact factor: 9.162

10.  Hormone replacement therapy and lung cancer risk: a case-control analysis.

Authors:  Matthew B Schabath; Xifeng Wu; Rena Vassilopoulou-Sellin; Ara A Vaporciyan; Margaret R Spitz
Journal:  Clin Cancer Res       Date:  2004-01-01       Impact factor: 12.531

View more
  22 in total

Review 1.  A potential role for estrogen in cigarette smoke-induced microRNA alterations and lung cancer.

Authors:  Amit Cohen; Mario Alberto Burgos-Aceves; Yoav Smith
Journal:  Transl Lung Cancer Res       Date:  2016-06

2.  Obesity in relation to lung cancer incidence in African American women.

Authors:  Traci N Bethea; Lynn Rosenberg; Marjory Charlot; George T O'Connor; Lucile L Adams-Campbell; Julie R Palmer
Journal:  Cancer Causes Control       Date:  2013-06-07       Impact factor: 2.506

3.  tRNA Fragments Show Intertwining with mRNAs of Specific Repeat Content and Have Links to Disparities.

Authors:  Aristeidis G Telonis; Phillipe Loher; Rogan Magee; Venetia Pliatsika; Eric Londin; Yohei Kirino; Isidore Rigoutsos
Journal:  Cancer Res       Date:  2019-04-17       Impact factor: 12.701

4.  Overexpression of estrogen receptor beta is a prognostic marker in non-small cell lung cancer: a meta-analysis.

Authors:  Zhuang Luo; Rongrong Wu; Yifeng Jiang; Zhixing Qiu; Wei Chen; Weimin Li
Journal:  Int J Clin Exp Med       Date:  2015-06-15

5.  Survival in women with NSCLC: the role of reproductive history and hormone use.

Authors:  Hannah Katcoff; Angela S Wenzlaff; Ann G Schwartz
Journal:  J Thorac Oncol       Date:  2014-03       Impact factor: 15.609

Review 6.  Influence of estrogen in non-small cell lung cancer and its clinical implications.

Authors:  Vianey Rodriguez-Lara; Juan-Manuel Hernandez-Martinez; Oscar Arrieta
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

Review 7.  Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potential.

Authors:  Ilaria Paterni; Carlotta Granchi; John A Katzenellenbogen; Filippo Minutolo
Journal:  Steroids       Date:  2014-06-24       Impact factor: 2.668

8.  Expression of metastasis-associated protein 2 (MTA2) might predict proliferation in non-small cell lung cancer.

Authors:  Shu-Li Liu; Yang Han; Yong Zhang; Cheng-Yao Xie; En-Hua Wang; Yuan Miao; Hai-Ying Li; Hong-Tao Xu; Shun-Dong Dai
Journal:  Target Oncol       Date:  2012-05-15       Impact factor: 4.493

9.  Use of the cytokinesis-blocked micronucleus assay to detect gender differences and genetic instability in a lung cancer case-control study.

Authors:  Michelle K McHugh; Mirtha S Lopez; Chung-Han Ho; Margaret R Spitz; Carol J Etzel; Randa A El-Zein
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-11-29       Impact factor: 4.254

Review 10.  Body mass index and risk of lung cancer: Systematic review and dose-response meta-analysis.

Authors:  Peng Duan; Chunhui Hu; Chao Quan; Xianfu Yi; Wei Zhou; Meng Yuan; Tingting Yu; Ansoumane Kourouma; Kedi Yang
Journal:  Sci Rep       Date:  2015-11-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.